Reports for PFIZER CANADA ULC
Company Name
PFIZER CANADA ULC
Totals |
||
Shortage reports |
750 |
|
Actual shortage: | 85 (11%) | |
Anticipated shortage: | 9 (1%) | |
Avoided shortage: | 48 (6%) | |
Resolved: | 608 (81%) | |
Discontinuation Reports |
87 |
|
To be discontinued: | 1 (1%) | |
Discontinued: | 85 (98%) | |
Reversed: | 1 (1%) | |
Late reports |
20 (2%) |
|
Overdue reports |
8 (8%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
LOMOTIL | .025MG 2.5MG | TABLET | Avoided shortage | 2017-06-29 | 2017-08-15 | 14416 |
LOMOTIL | .025MG 2.5MG | TABLET | Resolved | 2023-02-28 | 2023-10-17 | 185710 |
BREVICON 0.5/35 TABLETS (28-DAY PACK) | .035MG .5MG | TABLET | Resolved | 2018-02-28 | 2018-05-24 | 41332 |
BREVICON 0.5/35 TABLETS (28-DAY PACK) | .035MG .5MG | TABLET | Resolved | 2020-06-29 | 2021-03-10 | 119176 |
SCOPOLAMINE HYDROBROMIDE INJECTION USP | .4MG | SOLUTION | Resolved | 2017-11-24 | 2018-10-24 | 30651 |
BREVICON 0.5/35 TABLETS (28-DAY PACK) | .5MG .035MG | TABLET | Resolved | 2023-10-06 | 2023-10-28 | 206524 |
BREVICON 0.5/35 TABLETS (28-DAY PACK) | .5MG .035MG | TABLET | Actual shortage | 2024-05-03 | 2024-05-11 | 226997 |
SCOPOLAMINE HYDROBROMIDE INJECTION USP | .6MG | SOLUTION | Resolved | 2017-03-13 | 2017-09-01 | 1123 |
SCOPOLAMINE HYDROBROMIDE INJECTION USP | .6MG | SOLUTION | Resolved | 2017-09-28 | 2018-11-05 | 23832 |
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP | 0.01MG 20MG | SOLUTION SOLUTION | Resolved | 2021-06-09 | 2021-07-27 | 140620 |
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP | 0.01MG 20MG | SOLUTION SOLUTION | Resolved | 2022-07-14 | 2023-01-30 | 164619 |
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP | 0.01MG 20MG | SOLUTION SOLUTION | Actual shortage | 2023-07-12 | 2023-12-01 | 198413 |
SYNPHASIC 28 TABLETS | 0.035MG 0.5MG 1.0MG | TABLET | Resolved | 2020-09-18 | 2021-02-23 | 124566 |
BREVICON 0.5/35 TABLETS (21-DAY PACK) | 0.035MG 0.5MG | TABLET | Resolved | 2018-03-07 | 2018-04-24 | 42178 |
BREVICON 0.5/35 TABLETS (21-DAY PACK) | 0.035MG 0.5MG | TABLET | Resolved | 2020-06-29 | 2021-03-10 | 119171 |
SELECT 1/35 (28-DAY) | 0.035MG 1.0MG | TABLET | Resolved | 2020-06-29 | 2021-02-04 | 119182 |
SELECT 1/35 (21-DAY) | 0.035MG 1.0MG | TABLET | Anticipated shortage | 2024-05-03 | 2024-05-03 | 226994 |
BREVICON 1/35 TABLETS (21-DAY PACK) | 0.035MG 1MG | TABLET | Resolved | 2018-02-21 | 2018-03-21 | 40436 |
BREVICON 1/35 TABLETS (28-DAY PACK) | 0.035MG 1MG | TABLET | Resolved | 2019-08-21 | 2019-10-16 | 92052 |
BREVICON 1/35 TABLETS (28-DAY PACK) | 0.035MG 1MG | TABLET | Resolved | 2022-08-29 | 2022-10-21 | 168162 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MIDAZOLAM INJECTION | 5MG | SOLUTION | Reversed | 2020-10-07 | 2020-10-19 | 125902 |
ARICEPT RDT | 5MG | TABLET (ORALLY DISINTEGRATING) | To be discontinued | 2021-04-14 | 2021-04-14 | 137465 |
ROPIVACAINE HYDROCHLORIDE INJECTION USP | 5MG | SOLUTION | Discontinued | 2022-09-30 | 2022-10-02 | 170502 |
TRACE ELEMENTS INJECTION USP | 6.0MCG 0.42MG 1.67MG 0.37MG | SOLUTION | Discontinued | 2018-10-09 | 2019-03-13 | 63474 |
ZYVOXAM 600 MG | 600MG | TABLET | Discontinued | 2020-01-17 | 2022-01-17 | 103480 |
VIRACEPT | 625MG | TABLET TABLET | Discontinued | 2021-09-03 | 2021-10-29 | 145167 |
PACLITAXEL FOR INJECTION | 6MG | SOLUTION | Discontinued | 2017-07-11 | 2018-02-01 | 15446 |